TozinameranMeSH concept

https://apps.who.int/iris/bitstream/handle/10665/351395/WHO-2019-nCoV-vaccinesSAGE-recommendation-BNT162b2-2022.1-fre.pdf
2022
false
false
false
Switzerland
Tozinameran
BNT162 Vaccine
orientation
vaccine, nos
vaccination
vaccines
COVID-19 Vaccines
vaccination
preventive immunization/medication
world health organization
COVID-19
emergencies
Vaccins
vaccinia
orientation, nos
Vaccinia
Off-Label use

---
https://apps.who.int/iris/bitstream/handle/10665/338848/WHO-2019-nCoV-vaccines-SAGE_recommendation-BNT162b2-2021.1-fre.pdf
2021
false
false
false
Switzerland
mRNA Vaccines
Tozinameran
BNT162 Vaccine
public health guidelines
Vaccins
Vaccinia
emergencies
vaccination
Off-Label use
vaccination
preventive immunization/medication
vaccine, nos
vaccines
vaccinia
world health organization
vaccination
vaccinia
viral vaccines
coronavirus infections
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines

---
https://www.cbip.be/fr/articles/3518?folia=3503
2021
false
false
false
Belgium
French
journal article
ChAdOx1 nCoV-19 Vaccine
vaccination
Tozinameran
vaccine potency
mRNA Vaccines
Tozinameran
BNT162 Vaccine
pneumonia, viral
coronavirus infections
pandemics
viral vaccines
coronavirus infections
viral vaccines
coronavirus infections
COVID-19
COVID-19 Vaccines
COVID-19 Vaccines
vaccines, synthetic
mRNA Vaccine

---
https://www.usherbrooke.ca/baladocritique/archives/episode-39-etudes-sur-les-vaccins-bnt162b2-et-mrna-1273-contre-la-covid-19/
2021
Canada
pneumonia, viral
coronavirus infections
Tozinameran
BNT162 Vaccine
sound
vaccine, nos
vaccinia, nos
preventive immunization/medication
Vaccinia
Vaccins
Leber amaurosis
vaccines
vaccination
vaccination, nos
pandemics
viral vaccines
COVID-19
COVID-19 Vaccines

---
https://apps.who.int/iris/bitstream/handle/10665/342278/WHO-2019-nCoV-vaccines-SAGE-recommendation-BNT162b2-2021.2-fre.pdf
2021
false
false
false
Switzerland
COVID-19
COVID-19 Vaccines
Tozinameran
BNT162 Vaccine
public health guidelines
preventive immunization/medication
orientation
vaccine, nos
emergencies
COVID-19
vaccines
orientation, nos
vaccination
Off-Label use
vaccinia
world health organization

---
https://sante.gouv.fr//IMG/pdf/cosv-_note_du_30_septembre_relative_a_l_efficacite_comparee_pfizer-moderna.pdf
2021
false
false
false
France
COVID-19
COVID-19 Vaccines
covid-19, RNA-based vaccine
mRNA Vaccines
Tozinameran
BNT162 Vaccine
public health guidelines
Vaccins
counseling
orientation
preventive immunization/medication
vaccine potency
vocational guidance counselor
vaccine, nos
vaccination, nos
vaccination
vaccinia, nos
Vaccinia

---
https://apps.who.int/iris/bitstream/handle/10665/350977/WHO-2019-nCoV-vaccines-SAGE-recommendation-BNT162b2-2021.3-fre.pdf
2021
false
false
false
Switzerland
COVID-19
COVID-19 Vaccines
Tozinameran
BNT162 Vaccine
practice guideline
orientation
vaccine, nos
vaccination
Vaccins
vaccinia
vaccination
world health organization
emergencies
preventive immunization/medication
Vaccinia
orientation, nos
vaccines
Off-Label use

---
https://www.has-sante.fr/jcms/p_3227132/fr/strategie-de-vaccination-contre-le-sars-cov-2-place-du-vaccin-a-arnm-comirnaty-bnt162b2
2020
false
false
false
France
coronavirus infections
pneumonia, viral
mRNA vaccine
covid-19, RNA-based vaccine
adult
mass vaccination
immunization programs
immunization programs
aged
risk factors
mRNA Vaccines
Tozinameran
BNT162 Vaccine
public health guidelines
health planning guidelines
vaccination
vaccination
rna, messenger
pandemics
viral vaccines
pandemics
COVID-19
COVID-19 Vaccines
vaccines, synthetic
mRNA Vaccine

---